Loading clinical trials...
Loading clinical trials...
In this study, we seek to understand the effects of tolcapone, an FDA-approved COMT inhibitor, on reward choice and response inhibition, two measures we have previously shown to be altered in subjects...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, San Francisco
Collaborators
NCT05894980 · Unipolar Depression, Impulsive Behavior, and more
NCT04785677 · Stress Disorders, Traumatic, Stress Disorders, Traumatic, Acute, and more
NCT02740582 · Alcohol Abuse, Impulsive Behavior
NCT02595164 · Anorexia Nervosa, Bulimia Nervosa, and more
NCT01805401 · Impulsive Behavior, Suicidal Impulses
University of California, Berkeley
Berkeley, California
UCSF: Ernest Gallo Clinic and Research Center
Emeryville, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions